Product Information
ABACAVIR 300 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.5380 per EA under NDC 69097051403. Its NADAC has been published 434 times since May 2, 2018.
FDA first approved this application on Nov 21, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Cipla USA Inc.NDC
69097051403
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ABACAVIR SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA078119FDA Approved
11/21/2017
TE Code
AB
On Market Since
11/21/2017
Pharmacological Classes
Price Statistics
The NADAC for ABACAVIR 300 MG TABLET has been published 434 times since May 2, 2018, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5380 per EA |
|---|---|
| All-time high | $1.4415 (Oct 10, 2018) |
| All-time low | $0.4392 (Dec 22, 2021) |
| 52-week high | $0.6820 |
| 52-week low | $0.5380 |
| Median price | $0.6586 |
| Average price | $0.7294 |
| Largest weekly change | +59.4% (Feb 23, 2022) |
| Weeks tracked | 434 |
| Tracking since | May 2, 2018 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ABACAVIR 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ABACAVIR 300 MG TABLET, manufactured by Cipla USA Inc., is $0.5380 per EA (NDC 69097051403), effective Aug 19, 2026.
How has the price of ABACAVIR 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ABACAVIR 300 MG TABLET has declined 53.3%. It has been tracked across 434 weekly CMS publications since May 2, 2018.
What are the highest and lowest recorded NADAC prices for ABACAVIR 300 MG TABLET?
Since May 2, 2018, the NADAC for ABACAVIR 300 MG TABLET has ranged from a low of $0.4392 (Dec 22, 2021) to a high of $1.4415 (Oct 10, 2018), with a median of $0.6586 per EA.
Are there cheaper alternatives to ABACAVIR 300 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ABACAVIR 300 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ABACAVIR 300 MG TABLET?
ABACAVIR 300 MG TABLET (NDC 69097051403) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.